Next Article in Journal / Special Issue
Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001–2023
Previous Article in Journal
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data
Previous Article in Special Issue
Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities
 
 
Commentary

Article Versions Notes

Vaccines 2024, 12(6), 692; https://doi.org/10.3390/vaccines12060692
Action Date Notes Link
article xml file uploaded 20 June 2024 14:03 CEST Original file -
article xml uploaded. 20 June 2024 14:03 CEST Update https://www.mdpi.com/2076-393X/12/6/692/xml
article pdf uploaded. 20 June 2024 14:03 CEST Version of Record https://www.mdpi.com/2076-393X/12/6/692/pdf
article html file updated 20 June 2024 14:05 CEST Original file https://www.mdpi.com/2076-393X/12/6/692/html
Back to TopTop